Dineo Lioma is a visionary entrepreneur and MedTech innovator driven by a passion for innovation and the creation of impactful businesses that enhance healthcare and employment opportunities in Africa.
With a track record of founding three successful companies in the healthcare sector, Dineo is a serial entrepreneur. Currently serving as the Co-Founder and CEO of Deep Medical Therapeutics (DMT), she leads the charge in revolutionizing primary healthcare accessibility in South Africa. DMT utilizes digital platforms to offer affordable and high-quality diagnostic and treatment services, aiming to create a more accessible healthcare ecosystem. Furthermore, Dineo’s vision extends to leveraging health data generated by DMT’s services and deep machine learning to support research companies in developing tailored drugs and vaccines for the African population.
Previously, Dineo served as the Co-Founder and COO of CapeBio Technologies, where she spearheaded the development of South Africa’s first COVID-19 test kit, aimed at enhancing test kit accessibility during the pandemic. Additionally, she co-founded Incitech, a medical diagnostics company that introduced a revolutionary rapid HIV diagnostic device powered by nanotechnology.
In addition to her professional accomplishments, Dineo is a devoted mother of two, balancing her
entrepreneurial pursuits with her family life.
Location: South Africa
Job: Entrepreneur and MedTech innovator
Umi100 Honouree 2024